Cases of Interest – Darvon / Darvocet Lawsuits
UPDATE – April 2011 –
Darvon lawsuits and Darvocet lawsuits will be consolidated for pretrial proceedings as part of a multidistrict litigation (MDL), which will be centralized in the US District Court for the Eastern District of Kentucky.
Darvon and Darvocet lawsuits have been filed by users who suffered heart rhythm abnormalities, sometimes fatal.
Darvocet, a once popular pain medication, combines acetaminophen with propoxyphene (the active ingredient in the similar painkiller Darvon). The drugs were available for over 40 years before the FDA concluded that severe side effects of propoxyphene may cause changes to the electrical activity of the heart. These heart issues may increase the risk of heart arrythmias, myocardial infarction and sudden death. Both the brand name drugs and their generic equivalents have been pulled from the market.
Darvocet and Darvon lawsuits allege that the drug makers failed to adequately warn consumers or the medical community about the risk of serious and potentially fatal heart rhythm problems. By centralizing the Darvon and Darvocet lawsuits, courts hope to reduce the burden of duplicative discovery in different cases, avoid conflicting pretrial rulings from different judges and provide a more convenient setting for attorneys, courts and litigants. If a settlement agreement is not reached, cases may be remanded back to the federal district court where they were originally filed for trial.
Darvon / Darvocet Recall
In November of 2010, the FDA banned Darvon, Darvocet, and other brand/generic drugs containing propoxyphene. Xanodyne Pharmaceuticals, Inc. has agreed to recall Darvon® and Darvocet® due to the risk of serious sometimes fatal heart rhythm abnormalities in patients using propoxyphene-containing products.
Studies in healthy people taking normal doses of propoxyphene show proof of heart side effects.
The FDA action comes nearly six years after the drug was banned in the U.K., and nearly a year and a half after the European drug agency banned it.
Propoxyphene is a pain medication used to treat mild to moderate pain. It is a taken as a single-ingredient prescription propoxyphene, (e.g., Darvon), or in a combination with acetaminophen, (e,g., Darvocet). It is also marketed as Balacet, Dolene, E-Lor, Genagesic, Propacet 100, SK-65, SK-65 APAP, Trycet, and Wygesic.
Recent data indicate that propoxyphene causes significant changes to the electrical activity of the heart. These changes can result in potentially fatal abnormal heart rhythms (arrhythmia), which have been linked to serious adverse events including sudden death. In addition, the risk of a propoxyphene induced cardiac event may increase with changes in a patient’s status, including dehydration, medication changes, or decreased kidney function.
Darvon, Darvocet Recall Lawyer / Attorney
If you know somebody who suffered a heart attack or died while taking Darvon or Darvocet, contact my office today. We are interested in learning more about your situation. We are investigating the potential for lawsuits on behalf of people who have suffered a heart attack or died as a result of taking Darvon or Darvocet.
I offer a free consultation.
PLOUFF LAW OFFICES, P.C.